Screening for Placental Insufficiency in High-risk Pregnancies: Is Earlier Better?

Placenta

Volumn 29, Issue 12, 2008, Pages 1034-1040

  Costa, S L ^a   Proctor, L ^a   Dodd, J M ^a,b   Toal, M ^a   Okun, N ^a   Johnson, J A ^c   Windrim, R ^a   Kingdom, J C P ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Adverse perinatal outcome; First and second trimesters; Maternal serum screening; Placental morphology; Placental pathology; Uterine artery Doppler

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; PROTEIN A;

ADULT; ADVERSE OUTCOME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIRST TRIMESTER PREGNANCY; HELLP SYNDROME; HUMAN; INTRAUTERINE GROWTH RETARDATION; PLACENTA FUNCTION; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SECOND TRIMESTER PREGNANCY; STILLBIRTH;

ADULT; ARTERIES; EARLY DIAGNOSIS; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PILOT PROJECTS; PLACENTA; PLACENTAL INSUFFICIENCY; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PROSPECTIVE STUDIES; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER; YOUNG ADULT;

EID: 56249113278     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2008.09.004     Document Type: Article

References (38)

1. Viero S., Chaddha V., Alkazaleh F., Simchen M.J., Malik A., Kelly E., et al. Prognostic value of placental ultrasound in pregnancies complicated by absent end-diastolic flow velocity in the umbilical arteries. Placenta 25 (2004) 735-741
2. Moldenhauer J.S., Stanek J., Warshak C., Khoury J., and Sibai B. The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol 189 (2003) 1173-1177
3. Nordenvall M., Ullberg U., Laurin J., Lingman G., Sandstedt B., and Ulmsten U. Placental morphology in relation to umbilical artery blood velocity waveforms. Eur J Obstet Gynecol Reprod Biol 40 (1991) 179-190
4. Toal M., Keating S., Machin G., Dodd J., Adamson S.L., Windrim R.C., et al. Determinants of adverse perinatal outcome in high-risk women with abnormal uterine artery Doppler images. Am J Obstet Gynecol 198 330 (2008) e1-e7
5. Krebs C., Macara L.M., Leiser R., Bowman A.W., Greer I.A., and Kingdom J.C. Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. Am J Obstet Gynecol 175 (1996) 1534-1542
6. Cnossen J.S., Morris R.K., ter Riet G., Mol B.W., van der Post J.A., Coomarasamy A., et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ 178 (2008) 701-711
7. Pardi G., Cetin I., Marconi A.M., Bozzetti P., Buscaglia M., Makowski E.L., et al. Venous drainage of the human uterus: respiratory gas studies in normal and fetal growth-retarded pregnancies. Am J Obstet Gynecol 166 (1992) 699-706
8. Waller D.K., Lustig L.S., Cunningham G.C., Golbus M.S., and Hook E.B. Second-trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death. N Engl J Med 325 (1991) 6-10
9. Lepage N., Chitayat D., Kingdom J., and Huang T. Association between second-trimester isolated high maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies. Am J Obstet Gynecol 188 (2003) 1354-1359
10. Whittle W., Chaddha V., Wyatt P., Huppertz B., and Kingdom J. Ultrasound detection of placental insufficiency in women with 'unexplained' abnormal maternal serum screening results. Clin Genet 69 (2006) 97-104
11. Toal M., Chan C., Fallah S., Alkazaleh F., Chaddha V., Windrim R.C., et al. Usefulness of a placental profile in high-risk pregnancies. Am J Obstet Gynecol 196 363 (2007) e1-e7
12. Metzenbauer M., Hafner E., Hoefinger D., Schuchter K., Stangl G., Ogris E., et al. Three-dimensional ultrasound measurement of the placental volume in early pregnancy: method and correlation with biochemical placenta parameters. Placenta 22 (2001) 602-605
13. Martin A.M., Bindra R., Curcio P., Cicero S., and Nicolaides K.H. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 18 (2001) 583-586
14. Kagan K.O., Wright D., Valencia C., Maiz N., and Nicolaides K.H. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A. Hum Reprod 23 (2008) 1968-1975
15. Smith G.C., Stenhouse E.J., Crossley J.A., Aitken D.A., Cameron A.D., and Connor J.M. Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 87 (2002) 1762-1767
16. Dugoff L., Hobbins J.C., Malone F.D., Porter T.F., Luthy D., Comstock C.H., et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 191 (2004) 1446-1451
17. Bower S., Bewley S., and Campbell S. Improved prediction of preeclampsia by two-stage screening of uterine arteries using the early diastolic notch and color Doppler imaging. Obstet Gynecol 82 (1993) 78-83
18. Jauniaux E., Moscoso G., Campbell S., Gibb D., Driver M., and Nicolaides K.H. Correlation of ultrasound and pathologic findings of placental anomalies in pregnancies with elevated maternal serum alpha-fetoprotein. Eur J Obstet Gynecol Reprod Biol 37 (1990) 219-230
19. Kramer M.S., Platt R.W., Wen S.W., Joseph K.S., Allen A., Abrahamowicz M., et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 108 (2001) E35
20. ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 77 (2002) 67-75
21. Krantz D., Goetzl L., Simpson J.L., Thom E., Zachary J., Hallahan T.W., et al. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 191 (2004) 1452-1458
22. Smith G.C., Crossley J.A., Aitken D.A., Pell J.P., Cameron A.D., Connor J.M., et al. First-trimester placentation and the risk of antepartum stillbirth. JAMA 292 (2004) 2249-2254
23. Brownbill P., Edwards D., Jones C., Mahendran D., Owen D., Sibley C., et al. Mechanisms of alphafetoprotein transfer in the perfused human placental cotyledon from uncomplicated pregnancy. J Clin Invest 96 (1995) 2220-2226
24. Smith G.C., Shah I., Crossley J.A., Aitken D.A., Pell J.P., Nelson S.M., et al. Pregnancy-associated plasma protein A and alpha-fetoprotein and prediction of adverse perinatal outcome. Obstet Gynecol 107 (2006) 161-166
25. Hempstock J., Jauniaux E., Greenwold N., and Burton G.J. The contribution of placental oxidative stress to early pregnancy failure. Hum Pathol 34 (2003) 1265-1275
26. Kaufmann P., Black S., and Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 69 (2003) 1-7
27. Schaaps J.P., Tsatsaris V., Goffin F., Brichant J.F., Delbecque K., Tebache M., et al. Shunting the intervillous space: new concepts in human uteroplacental vascularization. Am J Obstet Gynecol 192 (2005) 323-332
28. Kingdom J.C., and Kaufmann P. Oxygen and placental villous development: origins of fetal hypoxia. Placenta 18 (1997) 613-621 [discussion 623-6]
29. Nevo O., Soleymanlou N., Wu Y., Xu J., Kingdom J., Many A., et al. Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol 291 (2006) R1085-R1093
30. Benirschke K., Kaufmann P., and Baergen R. Early development of the human placenta (2006), Springer, New York, NY
31. Fisk N.M., MacLachlan N., Ellis C., Tannirandorn Y., Tonge H.M., and Rodeck C.H. Absent end-diastolic flow in first trimester umbilical artery. Lancet 2 (1988) 1256-1257
32. Guibourdenche J., Frendo J.L., Pidoux G., Bertin G., Luton D., Muller F., et al. Expression of pregnancy-associated plasma protein-A (PAPP-A) during human villous trophoblast differentiation in vitro. Placenta 24 (2003) 532-539
33. Sun I.Y., Overgaard M.T., Oxvig C., and Giudice L.C. Pregnancy-associated plasma protein A proteolytic activity is associated with the human placental trophoblast cell membrane. J Clin Endocrinol Metab 87 (2002) 5235-5240
34. Laursen L.S., Kjaer-Sorensen K., Andersen M.H., and Oxvig C. Regulation of insulin-like growth factor (IGF) bioactivity by sequential proteolytic cleavage of IGF binding protein-4 and -5. Mol Endocrinol 21 (2007) 1246-1257
35. Conover C.A., Mason M.A., Levine J.A., and Novak C.M. Metabolic consequences of pregnancy-associated plasma protein-A deficiency in mice: exploring possible relationship to the longevity phenotype. J Endocrinol 198 (2008) 599-605
36. Pilalis A., Souka A.P., Antsaklis P., Daskalakis G., Papantoniou N., Mesogitis S., et al. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation. Ultrasound Obstet Gynecol 29 (2007) 135-140
37. Proctor L., Toal M., Keating S., Okun N., Windrim R., Smith G., et al. Prediction of adverse pregnancy outcomes in women with low pregnancy-associated plasma protein A. Abstracts of Perinatal Medicine 2008. June 2-4, 2008. Arch Dis Child Fetal Neonatal Ed 93 Suppl. 1 (2008) Fa41
38. Dodd J.M., Sahi K., McLeod A., Windrim R.C., and Kingdom J.P. Heparin therapy for complications of placental dysfunction: a systematic review of the literature. Acta Obstet Gynecol Scand 87 (2008) 804-811